<i>In vitro</i> and <i>in vivo</i> anticancer activity of Lycorine in prostate cancer by inhibiting NF-κB signaling pathway.

J Cancer · 2022 · PMC9414015 · PMID 36046655

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

p < 0.05 was considered as significant and p < 0.01 as highly significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.